Concepedia

E Llamas

EL

Statistics

Publications

4

Citations

265

H-Index

4

Active since

1995

Affiliations

Stanford University(Current)

Hospital Universitario Virgen Macarena

Steno Diabetes Centers

AstraZeneca (Sweden)

Saint Luke's Hospital

E Llamas is an author at Stanford University specializing in renal pharmacology, ckd progression, and immunology.

Publications per year

1995–2021

4

Publications

4

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

, , +15

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

, , +17

Enhancement of Antigen-specific functional responses by neutrophils from allergic patients.

M. J. Camacho, Ramón F. Montaño, E Llamas et al. · The Journal of Experimental Medicine · 1996 · 39 citations · Full text

, , +17

Peripheral blood T lymphocytes in seasonal bronchial asthma

P. Guardia, J. Delgado, E Llamas et al. · Allergy · 1995 · 10 citations

, , +17

1–4 of 4